阳普医疗 reported revenue of ¥0.22B for the period ended 2026-06-30, -6.9% year on year. Net income was ¥0.03B, a 14.6% net margin on a 47.7% gross margin. The largest revenue line is 真空采血系统 at 66% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | -6.9% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | +102.9% |
| Gross margin | 47.7% | Net margin 14.6% |
| Revenue Q/Q | +25.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 真空采血系统 | ¥0.14B | 65.9% |
| 试剂 | ¥0.03B | 14.4% |
| 检测服务 | ¥0.01B | 6.6% |
| 软件产品及服务 | ¥0.01B | 5.7% |
| 其他产品 | ¥0.01B | 4.5% |
| 仪器 | ¥0.01B | 2.8% |
| 微生物转运系统 | ¥0.00B | 0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.11B | 52.3% |
| R&D | ¥0.01B | 4.4% |
| SG&A | ¥0.06B | 27.7% |
| Tax & other | ¥0.01B | 2.7% |
| Item | Amount |
|---|---|
| Total assets | ¥0.99B |
| Total liabilities | ¥0.31B |
| Shareholders' equity | ¥0.68B |
| Equity / assets | 68.4% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 181% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
宝通科技 ・ 金龙机电 ・ 钢研高纳 ・ 中科电气 ・ 超图软件 ・ 新宙邦 ・ 上海凯宝 ・ 九洲集团 ・ 回天新材 ・ 朗科科技 ・ 星辉娱乐 ・ *ST赛为
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies